Imperative Care, Inc., a pioneer in advanced technologies for stroke and vascular care, has appointed Tyler Binney to its Board of Directors.
Binney brings deep leadership experience and a strong record of scaling healthcare companies through strategic growth, operational excellence, and successful acquisitions. Most recently, he served as President and CEO of Relievant Medsystems, where he guided the company’s commercial expansion and led its acquisition by Boston Scientific for over $850 million. His leadership helped position Relievant as a key innovator in the treatment of chronic low back pain.
Before his time at Relievant, Binney held several executive roles, including President and GM of Teleflex’s Interventional Urology division, and Vice President of Sales at NeoTract, where he played an integral role in its US$1.1 billion acquisition by Teleflex.
Currently, Binney also serves as Chairman of the Board at iO Urology, and holds board positions at Intrinsic Therapeutics and ProVerum Medical.
His appointment comes at a pivotal time for Imperative Care as the company continues to expand its portfolio of integrated solutions and accelerate its impact in the neurovascular space. Binney’s strategic insight and operational expertise will be vital in guiding the company’s next phase of growth.
